Trial intelligence / Profile preview

Photodynamic therapy for skin rejuvenation

2015-002537-22Phase 2Completed

Sponsor
Medical University of Vienna
Start
Dec 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of 5-aminolevulinic acid in photoaging and actinic elastosis, sponsored by Medical University of Vienna. Primary endpoint: Change in Photoaging Score. Started Dec 2016; status: completed.

02

Drugs

5-aminolevulinic acid
03

Conditions

photoagingactinic elastosis

Beyond the preview

Go deeper on 2015-002537-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-002537-22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call